Bioavailability is the fraction of a substance, whether a drug, nutrient, or supplement, that actually reaches your bloodstream in its active form after you take it. A medication injected directly into a vein has 100% bioavailability by definition, because every bit of it enters your circulation. Anything taken by another route (swallowed, inhaled, absorbed through the skin) will have lower bioavailability, because some portion gets lost or broken down along the way.
How Bioavailability Is Measured
Scientists measure bioavailability by tracking how much of a drug appears in the blood over time. They draw blood samples at regular intervals after a dose, measure the drug concentration at each point, and plot those values on a graph. The total area under that curve, often abbreviated AUC, represents the overall exposure your body gets to the drug. A larger area means more of the drug made it into circulation.
To calculate bioavailability, researchers compare the AUC from one route of administration (say, a pill you swallow) against the AUC from an intravenous dose of the same drug. If the oral dose produces an AUC that’s 40% of the IV dose, that drug has 40% oral bioavailability. This means 60% of the active ingredient was lost somewhere between your mouth and your bloodstream.
Why So Much Gets Lost: The First-Pass Effect
When you swallow a pill, it dissolves in your stomach or small intestine, and the drug is absorbed through the gut wall into blood vessels that lead directly to the liver. Before that drug ever reaches the rest of your body, the liver metabolizes a significant portion of it, breaking it down into inactive byproducts. This process is called the first-pass effect, and it’s the single biggest reason oral medications have lower bioavailability than injected ones.
The liver isn’t the only place this happens. Enzymes in the gut wall, the lungs, and other tissues can also break down a drug before it reaches its target. Some drugs lose so much to first-pass metabolism that taking them orally would be impractical, which is why certain medications are designed as injections, patches, or sublingual tablets (dissolved under the tongue, where the drug absorbs into blood vessels that bypass the liver entirely).
What Affects a Drug’s Bioavailability
Two properties of a drug largely determine how well it’s absorbed from the gut: how easily it dissolves in water (solubility) and how readily it passes through the intestinal lining (permeability). The FDA classifies drugs into four categories based on these traits. Drugs with high solubility and high permeability absorb well and reliably. Drugs with low solubility and low permeability are the hardest to formulate and tend to have the most unpredictable absorption.
But the drug itself is only part of the equation. Your individual biology matters too. People carry different versions of the liver enzymes responsible for breaking down medications. Someone whose enzymes work slowly (a “poor metabolizer”) may end up with much higher drug levels in their blood than someone whose enzymes work rapidly (an “ultra-rapid metabolizer”), even when both take the same dose. These genetic differences explain why the same medication can work perfectly for one person and cause side effects or feel ineffective for another.
Other factors that shift bioavailability include food in the stomach, other medications taken at the same time, gut health, age, and liver function. A fatty meal, for example, can dramatically increase absorption of certain drugs while slowing absorption of others.
Why It Matters for Generic Drugs
When a pharmaceutical company develops a generic version of a brand-name drug, it doesn’t need to repeat the original clinical trials. Instead, it must prove the generic is “bioequivalent,” meaning it delivers the same amount of drug to the bloodstream at roughly the same rate. The FDA requires the generic’s AUC and peak blood concentration to fall within 80% to 125% of the brand-name drug’s values, measured with a 90% confidence interval.
For most medications, this range is perfectly safe. But for drugs with a narrow therapeutic index, where the difference between an effective dose and a toxic one is small, even modest shifts in bioavailability can cause problems. Warfarin (a blood thinner), lithium (a mood stabilizer), certain seizure medications like phenytoin and carbamazepine, the heart drug digoxin, and opioid painkillers all fall into this category. Switching between brands of these drugs can sometimes lead to breakthrough symptoms or unexpected side effects, which is why doctors and pharmacists pay closer attention to brand consistency for these medications.
Bioavailability of Nutrients From Food
The concept extends well beyond pharmaceuticals. When nutritionists talk about bioavailability, they mean how much of a vitamin or mineral from food or a supplement your body actually absorbs and uses. The iron listed on a nutrition label, for instance, is not the iron your body gets. Plant-based iron is far less bioavailable than iron from meat, and what you eat alongside it makes a big difference.
Several compounds in food act as absorption enhancers. Vitamin C boosts iron absorption significantly. One study found that combining a specific enzyme (phytase) with vitamin C tripled iron absorption from a meal, pushing it from 2.4% to 7.4%. Dietary fat is essential for absorbing fat-soluble vitamins (A, D, E, and K), which is why taking a vitamin D supplement with a meal that contains some fat works better than taking it on an empty stomach. Probiotics can improve zinc absorption, and prebiotics (the fiber that feeds gut bacteria) appear to increase calcium absorption by keeping minerals in a soluble form.
On the other side, several compounds block nutrient absorption. Phytic acid, found in whole grains, legumes, nuts, and seeds, binds to calcium, zinc, and iron, pulling them through the digestive tract before they can be absorbed. Polyphenols in tea and coffee do something similar. High-fiber diets can reduce absorption of fat-soluble vitamins and carotenoids. Even medications play a role: proton pump inhibitors (common heartburn drugs) reduce absorption of dietary B12 and may lower calcium uptake, while metformin, widely prescribed for type 2 diabetes, is well known to contribute to B12 deficiency partly by reducing its absorption in the small intestine.
How Drug Makers Improve Bioavailability
Pharmaceutical companies use several strategies to get more of a poorly absorbed drug into your bloodstream. One of the most common is shrinking the drug particles down to nanometer scale. Smaller particles have more surface area exposed to digestive fluids, so they dissolve faster and more completely. Techniques like wet milling and high-pressure homogenization can reduce drug particles to sizes measured in billionths of a meter.
Another approach is wrapping the drug in fat-based delivery systems. Lipid nanoparticles, liposomes, and self-emulsifying formulations essentially disguise the drug in a form the gut is naturally good at absorbing. When these fat-based carriers hit the digestive tract, they trigger the body’s normal fat-digestion process, forming tiny droplets that carry the drug across the intestinal wall. This is particularly useful for drugs that don’t dissolve well in water on their own.
Sometimes chemists modify the drug molecule itself, creating what’s called a prodrug. The modified version is inactive but absorbs more easily. Once inside the body, enzymes convert it back into the active form. This lets the drug survive the journey through the gut and liver that would otherwise destroy it. The tradeoff is added complexity in development, since the conversion needs to happen reliably and completely.
What This Means in Practice
Understanding bioavailability helps explain several things you might encounter in everyday health decisions. It’s why your doctor might tell you to take a medication with food or on an empty stomach. It’s why two supplements containing the same listed amount of a nutrient can produce very different results. It’s why a 5 mg dose of one drug might be equivalent to a 20 mg dose of another, even if they contain the same active ingredient in different formulations. And it’s why switching between generic and brand-name versions of certain high-risk medications deserves a conversation with your pharmacist, especially for drugs where small concentration changes matter.